Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Evidence of First-line Treatment With Pediatric-like Protocol for Adolescents and Young Adults Patients Diagnosed With Philadelphia-negative Acute Lymphoblastic Leukemia

NCT05127148 is registered in ClinicalTrials.gov with Grupo Argentino de Tratamiento de la Leucemia Aguda as lead sponsor.

NCT NCT05127148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05127148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Evidence of First-line Treatment With Pediatric-like Protocol for Adolescents and Young Adults Patients Diagnosed With Philadelphia-negative Acute Lymphoblastic Leukemia
Lead sponsor
Grupo Argentino de Tratamiento de la Leucemia Aguda
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2021
Completion date
December 1, 2026
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, adult